About BPC-157 Research Laboratory research on BPC-157 has focused on its effects in preclinical tissue-repair and gut-protection models, including studies of angiogenesis, collagen organization, and protective signaling in gastrointestinal and musculoskeletal tissue models
its where our cells are attacked by free radicals which destroy DNA and skin proteins
Research published in Journal of Orthopaedic Research (2019) highlighted BPC-157s ability to reduce fibrotic markers and improve tissue remodeling in injured tendons
Studied for broader recovery and connective tissue pathway models
Per USP General Chapter (Aerosols, Nasal Sprays, Metered-Dose Inhalers, and Dry Powder Inhalers), the acceptance criteria require that at least 9 of 10 tested doses fall within 75125% of the labeled dose, with none outside the range of 65135%